TMA Precision Health
TMA Precision Health: Enhancing lives with genome sequencing for rare disease treatment.
Founded
2019TMA Precision Health: Enhancing lives with genome sequencing for rare disease treatment.
TMA Precision Health, founded with a mission to improve the lives of rare disease patients, focuses on ending the diagnostic odyssey for these individuals. The company offers genome sequencing services and a research platform that provides comprehensive information about diagnosed diseases, including related genes, repurposed drugs, existing care options, and active clinical trials. Their vision is to ensure that rare disease patients worldwide receive the medical care they need to lead happy and healthy lives.
Notable affiliated individuals and investors include experts in genomics and healthcare innovation, although specific names are not provided. Key achievements of TMA Precision Health include the development of their advanced research platform, which significantly accelerates the diagnostic process and treatment options for rare diseases. The overall impact of TMA Precision Health lies in its potential to transform the healthcare landscape for rare disease patients by providing timely and accurate diagnostic information, thereby improving patient outcomes and quality of life.
Companies similar to TMA Precision Health include Variantyx, Toma Biosciences, Rare Disease Data Trust and Probably Genetic.
TMA Precision Health was founded in 2019.
TMA Precision Health's headquarters is located in Boston, MA, US.
TMA Precision Health's most recent funding round was for $20k (USD) in August 2022.
As of Aug 5, 2022, TMA Precision Health has disclosed funding of $20k (USD). Undisclosed round amounts are excluded.
TMA Precision Health has 3 employees as of Feb 4, 2024.
Probably Genetic
